BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zając AE, Kopeć S, Szostakowski B, Spałek MJ, Fiedorowicz M, Bylina E, Filipowicz P, Szumera-Ciećkiewicz A, Tysarowski A, Czarnecka AM, Rutkowski P. Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers (Basel) 2021;13:2390. [PMID: 34069269 DOI: 10.3390/cancers13102390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao R, Wang Y, Li L, Dong Y, Zhao J, Liang W. Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations. Drug Deliv 2022;29:1631-47. [PMID: 35612368 DOI: 10.1080/10717544.2022.2075983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H. Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma. Int J Mol Sci 2022;23:1096. [PMID: 35163019 DOI: 10.3390/ijms23031096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Spanò DP, Bonelli S, Calligaris M, Carreca AP, Carcione C, Zito G, Nicosia A, Rizzo S, Scilabra SD. High-Resolution Secretome Analysis of Chemical Hypoxia Treated Cells Identifies Putative Biomarkers of Chondrosarcoma. Proteomes 2022;10:25. [DOI: 10.3390/proteomes10030025] [Reference Citation Analysis]
4 Lohberger B, Glänzer D, Kaltenegger H, Eck N, Leithner A, Bauer R, Kretschmer N, Steinecker-Frohnwieser B. Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation. BMC Cancer 2022;22:758. [PMID: 35820864 DOI: 10.1186/s12885-022-09857-x] [Reference Citation Analysis]
5 Tong Y, Cui Y, Jiang L, Pi Y, Gong Y, Zhao D. Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study. Front Public Health 2022;10:901680. [DOI: 10.3389/fpubh.2022.901680] [Reference Citation Analysis]
6 Garay Buitron F, Pons-Escoda A, Vidal N, Torres A, Camins A. Primary extraosseous dural chondrosarcoma: a case report. BMC Neurol 2021;21:489. [PMID: 34911493 DOI: 10.1186/s12883-021-02515-y] [Reference Citation Analysis]
7 LeBrun DG. CORR Insights®: Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis. Clin Orthop Relat Res 2021. [PMID: 34870951 DOI: 10.1097/CORR.0000000000002066] [Reference Citation Analysis]
8 Palmisciano P, Haider AS, Sabahi M, Nwagwu CD, Bin Alamer O, Scalia G, Umana GE, Cohen-Gadol AA, El Ahmadieh TY, Yu K, Pathmanaban ON. Primary Skull Base Chondrosarcomas: A Systematic Review. Cancers (Basel) 2021;13:5960. [PMID: 34885071 DOI: 10.3390/cancers13235960] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bădilă AE, Rădulescu DM, Niculescu AG, Grumezescu AM, Rădulescu M, Rădulescu AR. Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review. Cancers (Basel) 2021;13:4229. [PMID: 34439383 DOI: 10.3390/cancers13164229] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]